首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Identification of lncRNA–miRNA–mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant
Authors:Xin Zhao  Dong-Yang Tang  Xu Zuo  Tian-Dong Zhang  Cheng Wang
Institution:1. Department of Pharmacy, Xinxiang Central Hospital, Xinxiang, Henan, P. R. China

Zhao and Tang have contributed equally to this work.;2. Department of Experimental Management Center, Henan Institute of Science and Technology, Xinxiang, Henan, P. R. China;3. Department of Pharmacy, Xinxiang Central Hospital, Xinxiang, Henan, P. R. China;4. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, P. R. China

Abstract:To construct a long noncoding RNA (lncRNA)–microRNA (miRNA)–messenger RNA (mRNA) regulatory network related to epithelial ovarian cancer (EOC) cisplatin-resistant, differentially expressed genes (DEGs), differentially expressed lncRNAs (DELs), and differentially expressed miRNAs (DEMs) between MDAH and TOV-112D cells lines were identified. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted to analyze the biological functions of DEGs. Downstream mRNAs or upstream lncRNAs for miRNAs were analyzed at miRTarBase 7.0 or DIANA-LncBase V2, respectively. A total of 485 significant DEGs, 85 DELs, and 5 DEMs were identified. Protein–protein interaction (PPI) network of DEGs contrains 81 nodes and 141 edges was constructed, and 25 hub genes related to EOC cisplatin-resistant were identified. Subsequently, a lncRNA–miRNA–mRNA regulatory network contains 4 lncRNAs, 4 miRNAs, and 35 mRNAs was established. Taken together, our study provided evidence concerning the alteration genes involved in EOC cisplatin-resistant, which will help to unravel the mechanisms underlying drug resistant.
Keywords:cisplatin-resistant  epithelial ovarian cancer  lncRNA  miRNA  mRNA
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号